18.08. | Relay Therapeutics to Present Clinical Data on RLY-4008 at ESMO Congress |  |
18.08. | Relay Therapeutics to Present Clinical Data on RLY-4008 at ESMO Congress |  |
08.08. | INSIDER SELL : Relay Therapeutics |  |
04.08. | RELAY THERAPEUTICS : Reports Second Quarter 2022 Financial Results and Corporate Highlight.. |  |
04.08. | RELAY THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a.. |  |
04.08. | Relay Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months.. |  |
04.08. | Earnings Flash (RLAY) RELAY THERAPEUTICS Posts Q2 Revenue $365,000 |  |
04.08. | RELAY THERAPEUTICS, INC. : Results of Operations and Financial Condition (form 8-K) |  |
04.08. | Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highligh.. |  |
04.08. | Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highligh.. |  |
28.07. | Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate High.. |  |
27.07. | RELAY THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) |  |
27.07. | Relay Therapeutics, Inc. Announces Appointment of Sekar Kathiresan to the Board |  |
08.07. | INSIDER SELL : Relay Therapeutics |  |
27.06. | RELAY THERAPEUTICS : June 2022 Corporate Presentation |  |
27.06. | RELAY THERAPEUTICS : Discloses Anticipated Registrational Path for RLY-4008 in Cholangioca.. |  |
27.06. | RELAY THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financial Statements an.. |  |
27.06. | Relay Therapeutics Discloses Anticipated Registrational Path for RLY-4008 in Cholangioc.. |  |
27.06. | Relay Therapeutics Discloses Anticipated Registrational Path for RLY-4008 in Cholangioc.. |  |
16.06. | Relay Therapeutics Announces Timing of Virtual Analyst and Investor Event |  |
16.06. | Relay Therapeutics Announces Timing of Virtual Analyst and Investor Event |  |
27.05. | RELAY THERAPEUTICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year.. |  |
26.05. | Relay Therapeutics to Participate in Two Upcoming Investor Conferences |  |
26.05. | Relay Therapeutics to Participate in Two Upcoming Investor Conferences |  |
05.05. | Earnings Flash (RLAY) RELAY THERAPEUTICS Posts Q1 Revenue $419,000 |  |
05.05. | Earnings Flash (RLAY) RELAY THERAPEUTICS Posts Q1 Loss $-0.57, vs. Street Est of $-0.62 |  |
05.05. | RELAY THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a.. |  |
05.05. | RELAY THERAPEUTICS, INC. : Results of Operations and Financial Condition (form 8-K) |  |
05.05. | Relay Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31,.. |  |
05.05. | Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlight.. |  |
05.05. | Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlight.. |  |
03.05. | INSIDER SELL : Relay Therapeutics |  |
03.05. | Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 H.. |  |
28.04. | Relay Therapeutics to Announce First Quarter 2022 Financial Results and Corporate Highl.. |  |
28.04. | Relay Therapeutics to Announce First Quarter 2022 Financial Results and Corporate Highl.. |  |
18.04. | INSIDER SELL : Relay Therapeutics |  |
05.04. | INSIDER SELL : Relay Therapeutics |  |
03.03. | INSIDER SELL : Relay Therapeutics |  |
24.02. | RELAY THERAPEUTICS : Reports Fourth Quarter and Full Year 2021 Financial Results and Corpo.. |  |
24.02. | Earnings Flash (RLAY) RELAY THERAPEUTICS Posts Q4 Revenue $3.03M |  |
24.02. | RELAY THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a.. |  |
24.02. | RELAY THERAPEUTICS, INC. : Results of Operations and Financial Condition (form 8-K) |  |
24.02. | Relay Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, .. |  |
24.02. | Relay Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corp.. |  |
17.02. | Relay Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and .. |  |
17.02. | Relay Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and .. |  |
02.02. | Relay Therapeutics to Participate in Two Upcoming Investor Conferences |  |
21.01. | BB Biotech boucle l'année 2021 sur une perte |  |
11.01. | Certain Common Stock of Relay Therapeutics, Inc. are subject to a Lock-Up Agreement End.. |  |
11.01. | Certain Options of Relay Therapeutics, Inc. are subject to a Lock-Up Agreement Ending o.. |  |
11.01. | Certain Restricted Stock Units of Relay Therapeutics, Inc. are subject to a Lock-Up Agr.. |  |
10.01. | RELAY THERAPEUTICS, INC. : Regulation FD Disclosure (form 8-K) |  |
04.01. | Relay Therapeutics Doses First Patient in First-in-Human Cancer Drug Trial |  |
04.01. | Relay Therapeutics Announces Dosing of First Patient in First-in-Human Trial of RLY-260.. |  |
04.01. | Relay Therapeutics, Inc. Announces Dosing of First Patient in First-in-Human Trial of R.. |  |
03.01. | Relay Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference |  |
2021 | Relay Therapeutics Announces Preclinical Data that Support Clinical Development of RLY-.. |  |
2021 | Relay Therapeutics, Inc. Announces Preclinical Data that Support Clinical Development o.. |  |
2021 | RELAY THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) |  |
2021 | Relay Therapeutics, Inc. Announces Resignation of Dipchand Nishar as Class III Director.. |  |
2021 | RELAY THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a.. |  |
2021 | Relay Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Hi.. |  |
2021 | Relay Therapeutics Posts Narrower Q3 Loss, Sees Sufficient Funding Into 2025 |  |
2021 | Relay Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months.. |  |
2021 | RELAY THERAPEUTICS, INC. : Results of Operations and Financial Condition (form 8-K) |  |
2021 | Earnings Flash (RLAY) RELAY THERAPEUTICS Posts Q3 Loss $-0.66, vs. Street Est of $-0.64 |  |
2021 | Earnings Flash (RLAY) RELAY THERAPEUTICS Posts Q3 Revenue $666,000, vs. Street Est of $.. |  |
2021 | Relay Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Hi.. |  |
2021 | Relay Therapeutics to Announce Third Quarter 2021 Financial Results and Recent Corporat.. |  |
2021 | INSIDER SELL : Relay Therapeutics |  |
2021 | RELAY THERAPEUTICS : Announces Proposed Public Offering of Common Stock - Form 8-K |  |
2021 | RELAY THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Results of Operatio.. |  |
2021 | RELAY THERAPEUTICS : Shares Gain in Afternoon Trading |  |
2021 | Health Care Stocks Edging Higher Ahead of Wednesday Close |  |
2021 | Health Care Stocks Finding Increased Support This Afternoon |  |